It was a sharply higher close for the markets with the Dow gaining 97 points to 21,711 on strong earnings and upbeat new home sales. Nasdaq rose 10 points to 6,422.
On the upside
Boeing (NYSE: BA) reversed year ago losses to post a stronger than expected profit for the second quarter prompting the company to lift its full year forecast.
Brink's (NYSE: BCO) reported higher second quarter earnings and revenue.
Second quarter same store sales climbed 1.3% for Smart & Final Stores (Nasdaq: SFS).
On the downside
Triumph Group (NYSE: TGI) disappointed with first quarter earnings and revenue that fell far short of expectations.
The Food and Drug Administration rejected Eagle Pharmaceuticals' (Nasdaq: EGRX) heat stroke treatment Ryanodex.
Mizuho Securities downgraded Amedisys (Nasdaq: AMED) from a Buy rating to a Neutral rating.
In the broad market, advancing issues barely edged out decliners by a slim margin on the NYSE while decliners edged out advancers by nearly 9 to 8 on Nasdaq. The broader S&P 500 held steady at 2,477. Bitcoin dropped $35 to $2521.
